Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with

Ragnhild Helseth1, Thomas W Weiss2, Trine Baur Opstad1

  • 1Center for Clinical Heart Research, Department of Cardiology, Oslo University Hospital Ullevål, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.

Thrombosis Research
|October 18, 2015
PubMed

Insights

Circulating biomarkers in acute myocardial infarction (AMI) do not consistently reflect local gene expression in coronary thrombi or total ischemic time. These findings suggest a localized environment within atherothrombosis, potentially guiding targeted therapies.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Biomarker Discovery

Background:

  • Acute myocardial infarction (AMI) involves dynamic gene expression in coronary thrombi.
  • The relationship between circulating biomarkers, local gene expression, and ischemic time in AMI is not well understood.
  • Investigating soluble biomarkers' association with thrombi genes and ischemic duration is crucial for understanding AMI pathophysiology.

Purpose of the Study:

  • To determine if circulating biomarkers correlate with gene expression in coronary thrombi.
  • To assess the association between circulating biomarkers and total ischemic time in AMI patients.
  • To explore the localized nature of the atherothrombotic environment.

Main Methods:

  • Blood samples were collected from 33 AMI patients undergoing percutaneous coronary intervention (PCI).
  • A panel of biomarkers related to plaque rupture, platelet/endothelial activation, hemostasis, and inflammation were analyzed.
  • Proximity Extension Assay (Proseek Multiplex CVD I), ELISAs, and RT-PCR were employed for laboratory analyses.

Main Results:

  • Circulating P-selectin showed correlation with corresponding P-selectin gene expression in thrombi (r=0.530, p=0.002).
  • Plasma galectin 3, fractalkine, monocyte chemoattractant protein 1 (MCP-1), and caspase 8 inversely correlated with ischemic time (p <0.05).
  • Higher levels of plasma MCP-1, galectin 3, and epidermal growth factor (EGF) were observed in patients with shorter ischemic times (≤ 4 hours).

Conclusions:

  • Dynamic changes in circulating mediators were not mirrored by locally expressed genes in coronary thrombi.
  • The study suggests a confined biological milieu at the site of atherothrombosis.
  • These findings may have implications for developing selective therapeutic strategies in AMI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
754
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
440
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
727
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
970